1 / 6

DIABETIC NEPHROPATHY

Dr.Ranjit Unnikrishnan I., M.D.,. DIRECTOR & DIABETOLOGIST Dr.Mohan’s DIABETES SPECIALITIES CENTRE. Dr. Mohan’s DIABETES SPECIALITIES CENTRE, Gopalapuram, Chennai. Dr. Mohan’s DIABETES SPECIALITIES CENTRE, Anna Nagar, Chennai. India. Hyderabad. Chennai (Formerly Madras).

burt
Download Presentation

DIABETIC NEPHROPATHY

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Dr.Ranjit Unnikrishnan I., M.D., DIRECTOR & DIABETOLOGIST Dr.Mohan’sDIABETES SPECIALITIES CENTRE Dr. Mohan’s DIABETES SPECIALITIES CENTRE, Gopalapuram, Chennai Dr. Mohan’sDIABETES SPECIALITIES CENTRE, Anna Nagar, Chennai India Hyderabad Chennai (Formerly Madras) MADRAS DIABETES RESEARCH FOUNDATION, Gopalapuram, Chennai Dr. Mohan’s DIABETES SPECIALITIES CENTRE, Jubilee Hills, Hyderabad DIABETIC NEPHROPATHY

  2. DIABETIC NEPHROPATHY – MAGNITUDE OF THE PROBLEM Most important cause of morbidity and mortality in Type 1 diabetes – progression is faster 50% with clinical nephropathy reach ESRD by 10 years 75% with clinical nephropathy reach ESRD by 20 years In Type 2 diabetes mellitus progression is slower – 20% reach ESRD About 25 – 50% of all cases of ESRD is due to diabetes ? Racial factors ? Indians / Blacks more susceptible High economic burden on society

  3. NATURAL HISTORY OF NEPHROPATHY IN TYPE 1 DIABETES Normo albumi- nuria Stage of hyper- filtration Micro albumi- nuria Macro albumi- nuria Azotemia (Renal failure) End stage Renal disease 15 - 20 yrs 4 - 5 yrs 1 yrs

  4. Stages Designation Structural GFR UAE BP changes Stage I Hyperfiltration Glomerular = 150 may N or Hypertrophy Hypertrophy be  Stage II Normo  BM  20% - N N albuminuria thickness 30% Stage III Microalbuminuria Further  BM  GFR 20 - 200  thickness g/min -3mm of Hg MICROALBUMINURIA AND DIABETIC NEPHROPATHY STAGES

  5. MICROALBUMINURIA AND DIABETIC NEPHROPATHY STAGES Stages Designation Structural GFR UAE BP changes Stage Overt Clear and  >200 Hyper- IV Proteinuria Pronounced g/min tension abnormalities Dipstick positive Stage End stage Glomerular  >200 V Renal closure g/min Hyper- Disease tension

  6. PREVALENCE OF PROTEINURIA CLINIC BASED STUDY ON 1848 TYPE 2 DIABETIC INDIVIDUALS n=1848 Mohan V et al, Postgrad Med J. 2000;76:569-73.

More Related